See also this year's filing and all EDGAR filings for this company.
PDF Report 0001835567_2022_Pear_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001835567')"} |
Graph
Absolute values for 0001835567, Pear Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 5,253,000 |
| 2 | AssetsCurrent | 185,241,000 |
| 3 | PropertyPlantAndEquipment | 6,255,000 |
| 4 | remainder_Assets | 411,000 |
| 5 | LongTermLiabilities | 1,994,000 |
| 6 | LiabilitiesCurrent | 47,166,000 |
| 7 | remainder_Liabilities | 57,566,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 5,233,000 |
| 10 | GeneralAndAdministrativeExpense | 67,619,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 37,041,000 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 4,208,000 |
| 18 | remainder_NetIncome | 40,543,000 |
| 19 | remainder_ComprehensiveNetIncome | -1,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 197,160,000 |
| 1 | Liabilities | 106,726,000 |
| 2 | Expenses | 109,893,000 |
| 3 | Revenues | 4,208,000 |
| 4 | StockholdersEquity | 90,434,000 |
| 5 | NetIncome | -65,142,000 |
| 6 | ComprehensiveNetIncome | -65,143,000 |
| 7 | BaseVar | 229,265,500 |
| 8 | EconomicCapitalRatio | 1.23 |
Edgar->Model Mapping
Feature Distribution
